vs
Side-by-side financial comparison of Lifeway Foods, Inc. (LWAY) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $55.4M, roughly 1.4× Lifeway Foods, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 18.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-17.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 11.4%).
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
LWAY vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $75.5M |
| Net Profit | $2.5M | — |
| Gross Margin | 27.8% | 69.3% |
| Operating Margin | 6.8% | 22.7% |
| Net Margin | 4.6% | — |
| Revenue YoY | 18.0% | 27.7% |
| Net Profit YoY | 1688.1% | — |
| EPS (diluted) | $0.15 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $55.4M | $75.5M | ||
| Q3 25 | $57.1M | $54.5M | ||
| Q2 25 | $53.9M | $52.4M | ||
| Q1 25 | $46.1M | $46.0M | ||
| Q4 24 | $46.9M | $59.1M | ||
| Q3 24 | $46.1M | $80.5M | ||
| Q2 24 | $49.2M | $47.1M | ||
| Q1 24 | $44.6M | $43.8M |
| Q4 25 | $2.5M | — | ||
| Q3 25 | $3.5M | $8.8M | ||
| Q2 25 | $4.2M | $5.9M | ||
| Q1 25 | $3.5M | $3.0M | ||
| Q4 24 | $-160.0K | — | ||
| Q3 24 | $3.0M | $20.3M | ||
| Q2 24 | $3.8M | $-4.5M | ||
| Q1 24 | $2.4M | $-4.8M |
| Q4 25 | 27.8% | 69.3% | ||
| Q3 25 | 28.7% | 77.7% | ||
| Q2 25 | 28.6% | 76.5% | ||
| Q1 25 | 23.9% | 77.1% | ||
| Q4 24 | 25.3% | 76.4% | ||
| Q3 24 | 25.7% | 63.9% | ||
| Q2 24 | 27.0% | 77.4% | ||
| Q1 24 | 25.8% | 75.5% |
| Q4 25 | 6.8% | 22.7% | ||
| Q3 25 | 8.8% | 17.6% | ||
| Q2 25 | 10.8% | 12.7% | ||
| Q1 25 | 3.4% | 8.7% | ||
| Q4 24 | 1.5% | 22.6% | ||
| Q3 24 | 9.1% | 27.4% | ||
| Q2 24 | 11.0% | -4.6% | ||
| Q1 24 | 8.0% | -5.3% |
| Q4 25 | 4.6% | — | ||
| Q3 25 | 6.2% | 16.2% | ||
| Q2 25 | 7.9% | 11.2% | ||
| Q1 25 | 7.7% | 6.5% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 6.5% | 25.2% | ||
| Q2 24 | 7.7% | -9.6% | ||
| Q1 24 | 5.4% | -11.0% |
| Q4 25 | $0.15 | $0.26 | ||
| Q3 25 | $0.23 | $0.17 | ||
| Q2 25 | $0.28 | $0.12 | ||
| Q1 25 | $0.23 | $0.06 | ||
| Q4 24 | $0.00 | $0.40 | ||
| Q3 24 | $0.19 | $0.41 | ||
| Q2 24 | $0.25 | $-0.09 | ||
| Q1 24 | $0.16 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $85.8M | $130.3M |
| Total Assets | $105.6M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $97.5M | ||
| Q3 25 | $23.0M | $94.4M | ||
| Q2 25 | $21.2M | $96.0M | ||
| Q1 25 | $19.4M | $93.2M | ||
| Q4 24 | $16.7M | $101.0M | ||
| Q3 24 | $20.6M | $96.7M | ||
| Q2 24 | $14.6M | $96.8M | ||
| Q1 24 | $12.0M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | $2.5M | $102.0M |
| Q4 25 | $85.8M | $130.3M | ||
| Q3 25 | $82.8M | $115.3M | ||
| Q2 25 | $78.7M | $104.7M | ||
| Q1 25 | $74.2M | $97.1M | ||
| Q4 24 | $71.9M | $92.1M | ||
| Q3 24 | $71.5M | $71.1M | ||
| Q2 24 | $68.0M | $48.5M | ||
| Q1 24 | $63.5M | $51.0M |
| Q4 25 | $105.6M | $216.3M | ||
| Q3 25 | $109.5M | $202.9M | ||
| Q2 25 | $98.3M | $194.9M | ||
| Q1 25 | $93.7M | $196.2M | ||
| Q4 24 | $90.5M | $213.3M | ||
| Q3 24 | $91.3M | $220.7M | ||
| Q2 24 | $84.9M | $205.0M | ||
| Q1 24 | $82.8M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | 0.04× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $267.0K | $14.4M |
| Free Cash FlowOCF − Capex | $-17.4M | $14.4M |
| FCF MarginFCF / Revenue | -31.5% | 19.1% |
| Capex IntensityCapex / Revenue | 31.9% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.4M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $267.0K | $14.4M | ||
| Q3 25 | $6.9M | $9.7M | ||
| Q2 25 | $3.9M | $14.1M | ||
| Q1 25 | $-150.0K | $3.6M | ||
| Q4 24 | $-2.6M | $15.6M | ||
| Q3 24 | $7.5M | $11.0M | ||
| Q2 24 | $6.5M | $1.0M | ||
| Q1 24 | $1.5M | $11.2M |
| Q4 25 | $-17.4M | $14.4M | ||
| Q3 25 | $1.8M | $9.7M | ||
| Q2 25 | $1.6M | $14.1M | ||
| Q1 25 | $-2.4M | $3.6M | ||
| Q4 24 | $-3.8M | $15.6M | ||
| Q3 24 | $5.9M | $11.0M | ||
| Q2 24 | $5.1M | $1.0M | ||
| Q1 24 | $-923.0K | — |
| Q4 25 | -31.5% | 19.1% | ||
| Q3 25 | 3.1% | 17.7% | ||
| Q2 25 | 3.0% | 26.8% | ||
| Q1 25 | -5.1% | 7.7% | ||
| Q4 24 | -8.2% | 26.4% | ||
| Q3 24 | 12.8% | 13.7% | ||
| Q2 24 | 10.4% | 2.1% | ||
| Q1 24 | -2.1% | — |
| Q4 25 | 31.9% | 0.0% | ||
| Q3 25 | 9.0% | 0.0% | ||
| Q2 25 | 4.3% | 0.0% | ||
| Q1 25 | 4.8% | 0.1% | ||
| Q4 24 | 2.7% | 0.0% | ||
| Q3 24 | 3.3% | 0.0% | ||
| Q2 24 | 2.9% | 0.0% | ||
| Q1 24 | 5.5% | 0.0% |
| Q4 25 | 0.11× | — | ||
| Q3 25 | 1.96× | 1.10× | ||
| Q2 25 | 0.92× | 2.41× | ||
| Q1 25 | -0.04× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | 0.54× | ||
| Q2 24 | 1.73× | — | ||
| Q1 24 | 0.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
PBYI
Segment breakdown not available.
